These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 29086638)

  • 1. The Economic Theory of Patent Protection and Pandemic Influenza Vaccines: Do Patents Really Incentivize Innovation in the Field?
    Eccleston-Turner M
    Am J Law Med; 2016 May; 42(2-3):572-597. PubMed ID: 29086638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achieving clinical equality in an influenza pandemic: patent realities.
    Kane EM
    Seton Hall Law Rev; 2009; 39(4):1137-72. PubMed ID: 20718133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revitalizing the patent system to incentivize pharmaceutical innovation: the potential of claims with means-plus-function clauses.
    Tang WL
    Duke Law J; 2013 Feb; 62(5):1069-108. PubMed ID: 25330553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How drug life-cycle management patent strategies may impact formulary management.
    Berger J; Dunn JD; Johnson MM; Karst KR; Shear WC
    Am J Manag Care; 2016 Oct; 22(16 Suppl):S487-S495. PubMed ID: 28719222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
    Abelin A; Colegate T; Gardner S; Hehme N; Palache A
    Vaccine; 2011 Feb; 29(6):1135-8. PubMed ID: 21115061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology and Protection of Intellectual Property: Emerging Trends.
    Siri JGS; Fernando CAN; De Silva SNT
    Recent Pat Nanotechnol; 2020; 14(4):307-327. PubMed ID: 32532198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between the academic community and the pharmaceutical industry: the legislative background and its effect on spending on medical research and development.
    Matthews JH
    Clin Invest Med; 1996 Dec; 19(6):470-8. PubMed ID: 8959357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of patents to innovation: updated cross-industry comparisons with biopharmaceuticals.
    Cockburn I; Long G
    Expert Opin Ther Pat; 2015 Jul; 25(7):739-42. PubMed ID: 25927945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are patents impeding medical care and innovation?
    Gold ER; Kaplan W; Orbinski J; Harland-Logan S; N-Marandi S
    PLoS Med; 2010 Jan; 7(1):e1000208. PubMed ID: 20052274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in novel influenza vaccines: a patent review.
    Song JM
    J Microbiol; 2016 Jun; 54(6):403-12. PubMed ID: 27225456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress with human H5N1 vaccines: a perspective from industry.
    Palache B; Krause R
    Expert Rev Vaccines; 2009 Apr; 8(4):391-400. PubMed ID: 19348556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patenting nanotechnology.
    Lemley MA
    Stanford Law Rev; 2005 Nov; 58(2):601-30. PubMed ID: 16395838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza Vaccine Research funded by the European Commission FP7-Health-2013-Innovation-1 project.
    Liu H; Frijlink HW; Huckriede A; van Doorn E; Schmidt E; Leroy O; Rimmelzwaan G; McCullough K; Whelan M; Hak E
    Vaccine; 2016 Nov; 34(48):5845-5854. PubMed ID: 27793486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A free market solution for prescription drug crises.
    Baker D
    Int J Health Serv; 2004; 34(3):517-26. PubMed ID: 15346683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global drug diffusion and innovation with the medicines patent pool.
    Wang LX
    J Health Econ; 2022 Sep; 85():102671. PubMed ID: 36030748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diseases endemic in developing countries: how to incentivize innovation.
    Weilbaecher A
    Ann Health Law; 2009; 18(2):281-309, 7 p. preceding i. PubMed ID: 21950242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations for licensure of influenza vaccines with pandemic and prepandemic indications.
    Baylor NW; Houn F
    Curr Top Microbiol Immunol; 2009; 333():453-70. PubMed ID: 19768419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis.
    Ramezanpour B; Pronker ES; Kreijtz JH; Osterhaus AD; Claassen E
    Vaccine; 2015 Aug; 33(35):4349-58. PubMed ID: 26048779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.
    Rudenko L; Yeolekar L; Kiseleva I; Isakova-Sivak I
    Vaccine; 2016 Oct; 34(45):5436-5441. PubMed ID: 27593158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of patents and research and development incentives in biopharmaceutical innovation.
    Grabowski HG; DiMasi JA; Long G
    Health Aff (Millwood); 2015 Feb; 34(2):302-10. PubMed ID: 25646111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.